Balancing the costs and benefits of GLP-1s
Payer strategies for GLP-1 medications for weight loss
Read our latest research on GLP-1s
Commercial drug trends: Looking to 2026 and onward
Changes in healthcare legislation and drug manufacturer pricing strategies have made the projection of average wholesale price and ingredient cost trends all the more critical.

Slimming down costs: MFPs and anti-obesity models unpacked
Gain timely insights into the upcoming Medicare Part D Maximum Fair Prices (MFP) for 2026 and 2027. Explore how these changes will impact coverage, access, and the competitive landscape for generics and biosimilars. Plus, discover the transformative power of anti-obesity demonstration models and what they mean for the future of healthcare.

Building a long-range GLP-1 forecast: When could commercial health plans see a plateau?
GLP-1 drugs: We provide a framework for building a long-range forecast to help employers understand how trends may change over time.
Measuring how GLP-1 medications impact the total cost of care
Approaches to assessing and managing the effects of GLP-1 drugs on health and financial outcomes
